Studies have demonstrated that AMPK activation inhibits CRC cells from taking up glutamine, reducing α-KG production, which inhibits the behavior of chromatin-modifying enzymes namely Ten-Eleven Translocation 2 (TET2), thereby repressing the levels of metastasis-related genes (97). The gene discussed is PRKAA1; the disease is colorectal carcinoma.